Day One Biopharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Day One Biopharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Day One Biopharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $29.6M.
  • Day One Biopharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$211M, a 11.7% decline year-over-year.
  • Day One Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$206M, a 40.3% decline from 2022.
  • Day One Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$147M, a 102% decline from 2021.
  • Day One Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$72.7M, a 428% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$206M -$59.2M -40.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 -$147M -$74.2M -102% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 -$72.7M -$59M -428% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 -$13.8M +$1.12M +7.53% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 -$14.9M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.